Literature DB >> 30216821

Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis.

Toshiaki Iba1, Jerrold H Levy2, Tatsuhiko Hirota3, Makoto Hiki4, Koichi Sato5, Taisuke Murakami6, Isao Nagaoka7.   

Abstract

INTRODUCTION: Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis.
METHODS: Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining.
RESULTS: The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin.
CONCLUSION: Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antithrombin; Endothelium; Hyaluronan; Inflammation; Microcirculation; Sepsis; Syndecan-1

Mesh:

Substances:

Year:  2018        PMID: 30216821     DOI: 10.1016/j.thromres.2018.09.042

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

Review 1.  Glycocalyx in Endotoxemia and Sepsis.

Authors:  Michael S Goligorsky; Dong Sun
Journal:  Am J Pathol       Date:  2020-02-06       Impact factor: 4.307

2.  Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation-A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients.

Authors:  Michael Hultström; Karin Fromell; Anders Larsson; Barbro Persson; Bo Nilsson; Susan E Quaggin; Christer Betsholtz; Robert Frithiof; Miklos Lipcsey; Marie Jeansson
Journal:  Biomedicines       Date:  2022-06-06

3.  Anti-Inflammatory Activity of Orally Administered Monostroma nitidum Rhamnan Sulfate against Lipopolysaccharide-Induced Damage to Mouse Organs and Vascular Endothelium.

Authors:  Masahiro Terasawa; Keiichi Hiramoto; Ryota Uchida; Koji Suzuki
Journal:  Mar Drugs       Date:  2022-02-03       Impact factor: 5.118

4.  Crocin alleviates lipopolysaccharide-induced acute respiratory distress syndrome by protecting against glycocalyx damage and suppressing inflammatory signaling pathways.

Authors:  Dong Zhang; Bo-Yang Qi; Wei- Wei Zhu; Xiao Huang; Xiao-Zhi Wang
Journal:  Inflamm Res       Date:  2020-01-10       Impact factor: 4.575

5.  Plasma Antithrombin Activity during Long-Term Magnesium Sulfate Administration for Preeclampsia without Severe Hypertension.

Authors:  Kaori Moriuchi; Kaoru Kawasaki; Maako Hayashi; Akihiko Ueda; Yukio Yamanishi; Haruta Mogami; Kohei Fujita; Reona Shiro; Yoshie Yo; Masaki Mandai; Noriomi Matsumura
Journal:  Healthcare (Basel)       Date:  2022-08-19

6.  Secondary Dysfunction of the Intestinal Barrier in the Pathogenesis of Complications of Acute Poisoning.

Authors:  Ju Ju Ivnitsky; T V Schäfer; V L Rejniuk; O A Vakunenkova
Journal:  J Evol Biochem Physiol       Date:  2022-08-28       Impact factor: 1.621

7.  Antithrombin III ameliorates post-traumatic brain injury cerebral leukocyte mobilization enhancing recovery of blood brain barrier integrity.

Authors:  Mohamed ElSaadani; Syed M Ahmed; Christina Jacovides; Alfonso Lopez; Victoria E Johnson; Lewis J Kaplan; C William Schwab; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2021-02-01       Impact factor: 3.313

8.  A question is "what are the optimal targets for anticoagulant therapies?"

Authors:  Nobuyuki Yokoyama; Shunsuke Takaki; Masashi Yokose; Kaori Kuwabara; Akiko Anzai; Takako Hamada; Shizuka Kashiwagi; Kenta Okamura; Yoh Sugawara; Takahisa Goto
Journal:  J Intensive Care       Date:  2020-02-14

Review 9.  Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection.

Authors:  Hideshi Okada; Shozo Yoshida; Akira Hara; Shinji Ogura; Hiroyuki Tomita
Journal:  Microcirculation       Date:  2020-08-30       Impact factor: 2.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.